BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li S, Chen X, Zhang H, Liang X, Xiang Y, Yu C, Zen K, Li Y, Zhang CY. Differential expression of microRNAs in mouse liver under aberrant energy metabolic status. J Lipid Res. 2009;50:1756-1765. [PMID: 19372595 DOI: 10.1194/jlr.m800509-jlr200] [Cited by in Crossref: 142] [Cited by in F6Publishing: 74] [Article Influence: 11.8] [Reference Citation Analysis]
Number Citing Articles
1 Jordan SD, Krüger M, Willmes DM, Redemann N, Wunderlich FT, Brönneke HS, Merkwirth C, Kashkar H, Olkkonen VM, Böttger T, Braun T, Seibler J, Brüning JC. Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism. Nat Cell Biol 2011;13:434-46. [PMID: 21441927 DOI: 10.1038/ncb2211] [Cited by in Crossref: 352] [Cited by in F6Publishing: 330] [Article Influence: 35.2] [Reference Citation Analysis]
2 Zhang Q, Wang J, Li H, Zhang Y, Chu X, Yang J, Li Y. LncRNA Gm12664-001 ameliorates nonalcoholic fatty liver through modulating miR-295-5p and CAV1 expression. Nutr Metab (Lond) 2020;17:13. [PMID: 32042299 DOI: 10.1186/s12986-020-0430-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
3 Locke JM, Lango Allen H, Harries LW. A rare SNP in pre-miR-34a is associated with increased levels of miR-34a in pancreatic beta cells. Acta Diabetol 2014;51:325-9. [PMID: 23828613 DOI: 10.1007/s00592-013-0499-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
4 Landrier JF, Derghal A, Mounien L. MicroRNAs in Obesity and Related Metabolic Disorders. Cells. 2019;8. [PMID: 31404962 DOI: 10.3390/cells8080859] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 24.5] [Reference Citation Analysis]
5 Assmann TS, Milagro FI, Martínez JA. Crosstalk between microRNAs, the putative target genes and the lncRNA network in metabolic diseases. Mol Med Rep 2019;20:3543-54. [PMID: 31485667 DOI: 10.3892/mmr.2019.10595] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
6 Bala S, Marcos M, Szabo G. Emerging role of microRNAs in liver diseases. World J Gastroenterol. 2009;15:5633-5640. [PMID: 19960558 DOI: 10.3748/wjg.15.5633.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Baffy G. MicroRNAs in Nonalcoholic Fatty Liver Disease. J Clin Med. 2015;4:1977-1988. [PMID: 26690233 DOI: 10.3390/jcm4121953] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 7.8] [Reference Citation Analysis]
8 Szabo G, Csak T. Role of MicroRNAs in NAFLD/NASH. Dig Dis Sci. 2016;61:1314-1324. [PMID: 26769057 DOI: 10.1007/s10620-015-4002-4] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 10.0] [Reference Citation Analysis]
9 Liu Z, Wang Y, Borlak J, Tong W. Mechanistically linked serum miRNAs distinguish between drug induced and fatty liver disease of different grades. Sci Rep 2016;6:23709. [PMID: 27045805 DOI: 10.1038/srep23709] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
10 Greenberg JK, Xia J, Zhou X, Thatcher SR, Gu X, Ament SA, Newman TC, Green PJ, Zhang W, Robinson GE, Ben-Shahar Y. Behavioral plasticity in honey bees is associated with differences in brain microRNA transcriptome. Genes Brain Behav 2012;11:660-70. [PMID: 22409512 DOI: 10.1111/j.1601-183X.2012.00782.x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 34] [Article Influence: 7.3] [Reference Citation Analysis]
11 聂娇, 李昌平. 非酒精性脂肪性肝病中microRNA调控细胞凋亡的机制. 世界华人消化杂志 2015; 23(15): 2389-2396 [DOI: 10.11569/wcjd.v23.i15.2389] [Reference Citation Analysis]
12 Pogribny IP, Starlard-Davenport A, Tryndyak VP, Han T, Ross SA, Rusyn I, Beland FA. Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice. Lab Invest. 2010;90:1437-1446. [PMID: 20548288 DOI: 10.1038/labinvest.2010.113] [Cited by in Crossref: 132] [Cited by in F6Publishing: 130] [Article Influence: 12.0] [Reference Citation Analysis]
13 Hashimoto N, Tanaka T. Role of miRNAs in the pathogenesis and susceptibility of diabetes mellitus. J Hum Genet 2017;62:141-50. [PMID: 27928162 DOI: 10.1038/jhg.2016.150] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 8.0] [Reference Citation Analysis]
14 Choi SE, Kemper JK. Regulation of SIRT1 by microRNAs. Mol Cells 2013;36:385-92. [PMID: 24213676 DOI: 10.1007/s10059-013-0297-1] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 5.5] [Reference Citation Analysis]
15 Koushki M, Zare M, Shabani M, Teimouri M, Hosseini H, Babaei Khorzoughi R, Meshkani R. Resveratrol Reduces Lipid Accumulation through Upregulating the Expression of MicroRNAs Regulating Fatty Acid Bet Oxidation in Liver Cells: Evidence from In-vivo and In-vitro Studies. Iran J Pharm Res 2020;19:333-40. [PMID: 33224240 DOI: 10.22037/ijpr.2019.111745.13332] [Reference Citation Analysis]
16 Rottiers V, Näär AM. MicroRNAs in metabolism and metabolic disorders. Nat Rev Mol Cell Biol. 2012;13:239-250. [PMID: 22436747 DOI: 10.1038/nrm3313] [Cited by in Crossref: 728] [Cited by in F6Publishing: 679] [Article Influence: 80.9] [Reference Citation Analysis]
17 Fu T, Choi SE, Kim DH, Seok S, Suino-Powell KM, Xu HE, Kemper JK. Aberrantly elevated microRNA-34a in obesity attenuates hepatic responses to FGF19 by targeting a membrane coreceptor β-Klotho. Proc Natl Acad Sci USA. 2012;109:16137-16142. [PMID: 22988100 DOI: 10.1073/pnas.1205951109] [Cited by in Crossref: 100] [Cited by in F6Publishing: 99] [Article Influence: 11.1] [Reference Citation Analysis]
18 Mazloom H, Alizadeh S, Esfahani EN, Razi F, Meshkani R. Decreased expression of microRNA-21 is associated with increased cytokine production in peripheral blood mononuclear cells (PBMCs) of obese type 2 diabetic and non-diabetic subjects. Mol Cell Biochem 2016;419:11-7. [PMID: 27370645 DOI: 10.1007/s11010-016-2743-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
19 Mennigen JA, Panserat S, Larquier M, Plagnes-Juan E, Medale F, Seiliez I, Skiba-Cassy S. Postprandial regulation of hepatic microRNAs predicted to target the insulin pathway in rainbow trout. PLoS One 2012;7:e38604. [PMID: 22701681 DOI: 10.1371/journal.pone.0038604] [Cited by in Crossref: 59] [Cited by in F6Publishing: 53] [Article Influence: 6.6] [Reference Citation Analysis]
20 Kim Y, Lee DH, Park SH, Jeon TI, Jung CH. The interplay of microRNAs and transcription factors in autophagy regulation in nonalcoholic fatty liver disease. Exp Mol Med 2021;53:548-59. [PMID: 33879861 DOI: 10.1038/s12276-021-00611-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Gharib E, Montasser Kouhsari S, Izad M. Punica granatum L. Fruit Aqueous Extract Suppresses Reactive Oxygen Species-Mediated p53/p65/miR-145 Expressions followed by Elevated Levels of irs-1 in Alloxan-Diabetic Rats. Cell J 2018;19:520-7. [PMID: 29105385 DOI: 10.22074/cellj.2018.4550] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
22 Kaur K, Bhatia H, Datta M. MicroRNAs in hepatic pathophysiology in diabetes. World J Diabetes 2011; 2(10): 158-163 [PMID: 22013501 DOI: 10.4239/wjd.v2.i10.158] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
23 Kim W, Kyung Lee E. Post-transcriptional regulation in metabolic diseases. RNA Biol 2012;9:772-80. [PMID: 22664919 DOI: 10.4161/rna.20091] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
24 Nelson LE, Valentine RJ, Cacicedo JM, Gauthier MS, Ido Y, Ruderman NB. A novel inverse relationship between metformin-triggered AMPK-SIRT1 signaling and p53 protein abundance in high glucose-exposed HepG2 cells. Am J Physiol Cell Physiol 2012;303:C4-C13. [PMID: 22378745 DOI: 10.1152/ajpcell.00296.2011] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 5.8] [Reference Citation Analysis]
25 Rottiers V, Näär AM. MicroRNAs in metabolism and metabolic disorders. Nat Rev Mol Cell Biol. 2012;13:239-250. [PMID: 22436747 DOI: 10.1038/nrm3328] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
26 Bala S, Marcos M, Szabo G. Emerging role of microRNAs in liver diseases. World J Gastroenterol 2009; 15(45): 5633-5640 [PMID: 19960558 DOI: 10.3748/wjg.15.5633] [Cited by in CrossRef: 104] [Cited by in F6Publishing: 107] [Article Influence: 8.7] [Reference Citation Analysis]
27 Derghal A, Djelloul M, Airault C, Pierre C, Dallaporta M, Troadec JD, Tillement V, Tardivel C, Bariohay B, Trouslard J, Mounien L. Leptin is required for hypothalamic regulation of miRNAs targeting POMC 3'UTR. Front Cell Neurosci 2015;9:172. [PMID: 25999818 DOI: 10.3389/fncel.2015.00172] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
28 Celikbilek M, Baskol M, Taheri S, Deniz K, Dogan S, Zararsiz G, Gursoy S, Guven K, Ozbakır O, Dundar M, Yucesoy M. Circulating microRNAs in patients with non-alcoholic fatty liver disease. World J Hepatol 2014; 6(8): 613-620 [PMID: 25232454 DOI: 10.4254/wjh.v6.i8.613] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 6.7] [Reference Citation Analysis]
29 Lendvai G, Jármay K, Karácsony G, Halász T, Kovalszky I, Baghy K, Wittmann T, Schaff Z, Kiss A. Elevated miR-33a and miR-224 in steatotic chronic hepatitis C liver biopsies. World J Gastroenterol 2014; 20(41): 15343-15350 [PMID: 25386083 DOI: 10.3748/wjg.v20.i41.15343] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
30 Iacomino G, Russo P, Stillitano I, Lauria F, Marena P, Ahrens W, De Luca P, Siani A. Circulating microRNAs are deregulated in overweight/obese children: preliminary results of the I.Family study. Genes Nutr 2016;11:7. [PMID: 27551310 DOI: 10.1186/s12263-016-0525-3] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 6.8] [Reference Citation Analysis]
31 Han H, Peng J, Hong Y, Zhang M, Han Y, Fu Z, Shi Y, Xu J, Tao J, Lin J. Comparison of the differential expression miRNAs in Wistar rats before and 10 days after S.japonicum infection. Parasit Vectors 2013;6:120. [PMID: 23617945 DOI: 10.1186/1756-3305-6-120] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
32 Xiao J, Bei Y, Liu J, Dimitrova-Shumkovska J, Kuang D, Zhou Q, Li J, Yang Y, Xiang Y, Wang F. miR-212 downregulation contributes to the protective effect of exercise against non-alcoholic fatty liver via targeting FGF-21. J Cell Mol Med. 2016;20:204-216. [PMID: 26648452 DOI: 10.1111/jcmm.12733] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 5.5] [Reference Citation Analysis]
33 Adi N, Adi J, Lassance-Soares RM, Kurlansky P, Yu H, Webster KA. High protein/fish oil diet prevents hepatic steatosis in NONcNZO10 mice; association with diet/genetics-regulated micro-RNAs. J Diabetes Metab 2016;7:676. [PMID: 28529818 DOI: 10.4172/2155-6156.1000676] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
34 Assmann TS, Recamonde-Mendoza M, De Souza BM, Crispim D. MicroRNA expression profiles and type 1 diabetes mellitus: systematic review and bioinformatic analysis. Endocr Connect 2017;6:773-90. [PMID: 28986402 DOI: 10.1530/EC-17-0248] [Cited by in Crossref: 57] [Cited by in F6Publishing: 34] [Article Influence: 14.3] [Reference Citation Analysis]
35 Fatima A, Waters S, O'Boyle P, Seoighe C, Morris DG. Alterations in hepatic miRNA expression during negative energy balance in postpartum dairy cattle. BMC Genomics. 2014;15:28. [PMID: 24428929 DOI: 10.1186/1471-2164-15-28] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
36 Hayes CN, Chayama K. MicroRNAs as Biomarkers for Liver Disease and Hepatocellular Carcinoma. Int J Mol Sci. 2016;17:280. [PMID: 26927063 DOI: 10.3390/ijms17030280] [Cited by in Crossref: 112] [Cited by in F6Publishing: 109] [Article Influence: 22.4] [Reference Citation Analysis]
37 Liu H, French BA, Li J, Tillman B, French SW. Altered regulation of miR-34a and miR-483-3p in alcoholic hepatitis and DDC fed mice. Exp Mol Pathol 2015;99:552-7. [PMID: 26403328 DOI: 10.1016/j.yexmp.2015.09.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
38 Chen S, Chen D, Yang H, Wang X, Wang J, Xu C. Uric acid induced hepatocytes lipid accumulation through regulation of miR-149-5p/FGF21 axis. BMC Gastroenterol. 2020;20:39. [PMID: 32070295 DOI: 10.1186/s12876-020-01189-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
39 Keller P, Gburcik V, Petrovic N, Gallagher IJ, Nedergaard J, Cannon B, Timmons JA. Gene-chip studies of adipogenesis-regulated microRNAs in mouse primary adipocytes and human obesity. BMC Endocr Disord 2011;11:7. [PMID: 21426570 DOI: 10.1186/1472-6823-11-7] [Cited by in Crossref: 81] [Cited by in F6Publishing: 78] [Article Influence: 8.1] [Reference Citation Analysis]
40 Huang ZZ, Wei JY, Ou-Yang HD, Li D, Xu T, Wu SL, Zhang XL, Liu CC, Ma C, Xin WJ. mir-500-Mediated GAD67 Downregulation Contributes to Neuropathic Pain. J Neurosci 2016;36:6321-31. [PMID: 27277808 DOI: 10.1523/JNEUROSCI.0646-16.2016] [Cited by in Crossref: 23] [Cited by in F6Publishing: 10] [Article Influence: 5.8] [Reference Citation Analysis]
41 Torres JL, Novo-Veleiro I, Manzanedo L, Alvela-Suárez L, Macías R, Laso FJ, Marcos M. Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease. World J Gastroenterol 2018; 24(36): 4104-4118 [PMID: 30271077 DOI: 10.3748/wjg.v24.i36.4104] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 31] [Article Influence: 11.7] [Reference Citation Analysis]
42 Andoorfar S, Hosseini Tafreshi SA, Rezvani Z. Assessment of the expression level of miRNA molecules using a semi-quantitative RT-PCR approach. Mol Biol Rep. 2019;46:5057-5062. [PMID: 31286390 DOI: 10.1007/s11033-019-04959-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
43 Paul S, Maji P. Rough sets for in silico identification of differentially expressed miRNAs. Int J Nanomedicine 2013;8 Suppl 1:63-74. [PMID: 24098080 DOI: 10.2147/IJN.S40739] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
44 McDaniel K, Herrera L, Zhou T, Francis H, Han Y, Levine P, Lin E, Glaser S, Alpini G, Meng F. The functional role of microRNAs in alcoholic liver injury. J Cell Mol Med. 2014;18:197-207. [PMID: 24400890 DOI: 10.1111/jcmm.12223] [Cited by in Crossref: 77] [Cited by in F6Publishing: 77] [Article Influence: 11.0] [Reference Citation Analysis]
45 Ali S, Nafis S, Kalaiarasan P, Rai E, Sharma S, Bamezai RN. Understanding Genetic Heterogeneity in Type 2 Diabetes by Delineating Physiological Phenotypes: SIRT1 and its Gene Network in Impaired Insulin Secretion. Rev Diabet Stud. 2016;13:17-34. [PMID: 27563694 DOI: 10.1900/rds.2016.13.17] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
46 Xie H, Sun L, Lodish HF. Targeting microRNAs in obesity. Expert Opin Ther Targets 2009;13:1227-38. [PMID: 19650761 DOI: 10.1517/14728220903190707] [Cited by in Crossref: 75] [Cited by in F6Publishing: 65] [Article Influence: 6.3] [Reference Citation Analysis]
47 Cai P, Piao X, Liu S, Hou N, Wang H, Chen Q. MicroRNA-gene expression network in murine liver during Schistosoma japonicum infection. PLoS One 2013;8:e67037. [PMID: 23825609 DOI: 10.1371/journal.pone.0067037] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
48 Cao C, Duan P, Li W, Guo Y, Zhang J, Gui Y, Yuan S. Lack of miR-379/miR-544 Cluster Resists High-Fat Diet-Induced Obesity and Prevents Hepatic Triglyceride Accumulation in Mice. Front Cell Dev Biol 2021;9:720900. [PMID: 34527673 DOI: 10.3389/fcell.2021.720900] [Reference Citation Analysis]
49 McGill MR, Jaeschke H. MicroRNAs as Signaling Mediators and Biomarkers of Drug- and Chemical-Induced Liver Injury. J Clin Med. 2015;4:1063-1078. [PMID: 26167291 DOI: 10.3390/jcm4051063] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.8] [Reference Citation Analysis]
50 Cossiga V, Lembo V, Nigro C, Mirra P, Miele C, D'Argenio V, Leone A, Mazzone G, Veneruso I, Guido M, Beguinot F, Caporaso N, Morisco F. The Combination of Berberine, Tocotrienols and Coffee Extracts Improves Metabolic Profile and Liver Steatosis by the Modulation of Gut Microbiota and Hepatic miR-122 and miR-34a Expression in Mice. Nutrients 2021;13:1281. [PMID: 33924725 DOI: 10.3390/nu13041281] [Reference Citation Analysis]
51 Paul S, Maji P. μHEM for identification of differentially expressed miRNAs using hypercuboid equivalence partition matrix. BMC Bioinformatics 2013;14:266. [PMID: 24006840 DOI: 10.1186/1471-2105-14-266] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
52 Baselga-Escudero L, Arola-Arnal A, Pascual-Serrano A, Ribas-Latre A, Casanova E, Salvadó MJ, Arola L, Blade C. Chronic administration of proanthocyanidins or docosahexaenoic acid reverses the increase of miR-33a and miR-122 in dyslipidemic obese rats. PLoS One 2013;8:e69817. [PMID: 23922812 DOI: 10.1371/journal.pone.0069817] [Cited by in Crossref: 56] [Cited by in F6Publishing: 45] [Article Influence: 7.0] [Reference Citation Analysis]
53 Chen F, Zhang H, Li J, Tian Y, Xu J, Chen L, Wei J, Zhao N, Yang X, Zhang W, Lu L. Identification of differentially expressed miRNAs in the fatty liver of Landes goose (Anser anser). Sci Rep 2017;7:16296. [PMID: 29176640 DOI: 10.1038/s41598-017-16632-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
54 Kostyniuk DJ, Marandel L, Jubouri M, Dias K, de Souza RF, Zhang D, Martyniuk CJ, Panserat S, Mennigen JA. Profiling the rainbow trout hepatic miRNAome under diet-induced hyperglycemia. Physiol Genomics 2019;51:411-31. [PMID: 31282806 DOI: 10.1152/physiolgenomics.00032.2019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
55 Gori M, Arciello M, Balsano C. MicroRNAs in nonalcoholic fatty liver disease: novel biomarkers and prognostic tools during the transition from steatosis to hepatocarcinoma. Biomed Res Int. 2014;2014:741465. [PMID: 24745023 DOI: 10.1155/2014/741465] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 5.9] [Reference Citation Analysis]
56 Latorre J, Moreno-Navarrete JM, Mercader JM, Sabater M, Rovira Ò, Gironès J, Ricart W, Fernández-Real JM, Ortega FJ. Decreased lipid metabolism but increased FA biosynthesis are coupled with changes in liver microRNAs in obese subjects with NAFLD. Int J Obes (Lond) 2017;41:620-30. [PMID: 28119530 DOI: 10.1038/ijo.2017.21] [Cited by in Crossref: 55] [Cited by in F6Publishing: 57] [Article Influence: 13.8] [Reference Citation Analysis]
57 Alipour MR, Naderi R, Alihemmati A, Sheervalilou R, Ghiasi R. Swimming training attenuates pancreatic apoptosis through miR-34a/Sirtu in1/P53 Axis in high-fat diet and Streptozotocin-induced Type-2 diabetic rats. J Diabetes Metab Disord 2020;19:1439-46. [PMID: 33520845 DOI: 10.1007/s40200-020-00670-6] [Reference Citation Analysis]
58 Daimiel-Ruiz L, Klett-Mingo M, Konstantinidou V, Micó V, Aranda JF, García B, Martínez-Botas J, Dávalos A, Fernández-Hernando C, Ordovás JM. Dietary lipids modulate the expression of miR-107, an miRNA that regulates the circadian system. Mol Nutr Food Res 2015;59:552-65. [PMID: 25522185 DOI: 10.1002/mnfr.201400616] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
59 He Z, Hu C, Jia W. miRNAs in non-alcoholic fatty liver disease. Front Med. 2016;10:389-396. [PMID: 27680976 DOI: 10.1007/s11684-016-0468-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
60 Nie H, Yu X, He H, Zhou L, Li Q, Song C, Wang D, Ren T, Chen Z, Huang H, Dai X, Zhou Y. Hepatocyte miR-33a mediates mitochondrial dysfunction and hepatosteatosis by suppressing NDUFA5. J Cell Mol Med 2018;22:6285-93. [PMID: 30324697 DOI: 10.1111/jcmm.13918] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
61 Lim E, Lim JY, Kim E, Kim YS, Shin JH, Seok PR, Jung S, Yoo SH, Kim Y. Xylobiose, an Alternative Sweetener, Ameliorates Diabetes-Related Metabolic Changes by Regulating Hepatic Lipogenesis and miR-122a/33a in db/db Mice. Nutrients 2016;8:E791. [PMID: 27929393 DOI: 10.3390/nu8120791] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
62 Gamazon ER, Nicolae DL, Cox NJ. A study of CNVs as trait-associated polymorphisms and as expression quantitative trait loci. PLoS Genet 2011;7:e1001292. [PMID: 21304891 DOI: 10.1371/journal.pgen.1001292] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 3.9] [Reference Citation Analysis]
63 Zarfeshani A, Ngo S, Sheppard AM. MicroRNA Expression Relating to Dietary-Induced Liver Steatosis and NASH. J Clin Med. 2015;4:1938-1950. [PMID: 26580662 DOI: 10.3390/jcm4111938] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
64 Shin BC, Ghosh S, Dai Y, Byun SY, Calkins KL, Devaskar SU. Early life high-fat diet exposure maintains glucose tolerance and insulin sensitivity with a fatty liver and small brain size in the adult offspring. Nutr Res 2019;69:67-81. [PMID: 31639589 DOI: 10.1016/j.nutres.2019.08.004] [Reference Citation Analysis]
65 Tian WH, Wang Z, Yue YX, Li H, Li ZJ, Han RL, Tian YD, Kang XT, Liu XJ. miR-34a-5p Increases Hepatic Triglycerides and Total Cholesterol Levels by Regulating ACSL1 Protein Expression in Laying Hens. Int J Mol Sci 2019;20:E4420. [PMID: 31500376 DOI: 10.3390/ijms20184420] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
66 Li K, Zhao B, Wei D, Wang W, Cui Y, Qian L, Liu G. miR‑146a improves hepatic lipid and glucose metabolism by targeting MED1. Int J Mol Med 2020;45:543-55. [PMID: 31894315 DOI: 10.3892/ijmm.2019.4443] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
67 Li WD, Xia JR, Lian YS. Hepatic miR‑215 target Rictor and modulation of hepatic insulin signalling in rats. Mol Med Rep 2019;19:3723-31. [PMID: 30896868 DOI: 10.3892/mmr.2019.10031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
68 Miao LH, Lin Y, Huang X, Pan WJ, Zhou QL, Liu B, Ren MC, Ge XP, Pan LK. In Vivo Analysis of miR-34a Regulated Glucose Metabolism Related Genes in Megalobrama amblycephala. Int J Mol Sci 2018;19:E2417. [PMID: 30115855 DOI: 10.3390/ijms19082417] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
69 Gui J, Tian Y, Wen X, Zhang W, Zhang P, Gao J, Run W, Tian L, Jia X, Gao Y. Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies. Clin Sci (Lond) 2011;120:183-93. [PMID: 20815808 DOI: 10.1042/CS20100297] [Cited by in Crossref: 147] [Cited by in F6Publishing: 103] [Article Influence: 14.7] [Reference Citation Analysis]
70 Mattis AN, Song G, Hitchner K, Kim RY, Lee AY, Sharma AD, Malato Y, McManus MT, Esau CC, Koller E. A screen in mice uncovers repression of lipoprotein lipase by microRNA-29a as a mechanism for lipid distribution away from the liver. Hepatology. 2015;61:141-152. [PMID: 25131933 DOI: 10.1002/hep.27379] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 6.0] [Reference Citation Analysis]
71 Yu J, Peng J, Luan Z, Zheng F, Su W. MicroRNAs as a Novel Tool in the Diagnosis of Liver Lipid Dysregulation and Fatty Liver Disease. Molecules 2019;24:E230. [PMID: 30634538 DOI: 10.3390/molecules24020230] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
72 Ding J, Li M, Wan X, Jin X, Chen S, Yu C, Li Y. Effect of miR-34a in regulating steatosis by targeting PPARα expression in nonalcoholic fatty liver disease. Sci Rep. 2015;5:13729. [PMID: 26330104 DOI: 10.1038/srep13729] [Cited by in Crossref: 116] [Cited by in F6Publishing: 118] [Article Influence: 19.3] [Reference Citation Analysis]
73 Mao Y, Mohan R, Zhang S, Tang X. MicroRNAs as pharmacological targets in diabetes. Pharmacol Res 2013;75:37-47. [PMID: 23810798 DOI: 10.1016/j.phrs.2013.06.005] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 6.1] [Reference Citation Analysis]
74 Jordan SD, Krüger M, Willmes DM, Redemann N, Wunderlich FT, Brönneke HS, Merkwirth C, Kashkar H, Olkkonen VM, Böttger T. Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism. Nat Cell Biol. 2011;13:434-446. [PMID: 21441927 DOI: 10.1038/ncb2211;] [Cited by in F6Publishing: 1] [Reference Citation Analysis]